446 related articles for article (PubMed ID: 19151620)
1. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H
J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the Nijmegen breakage syndrome gene in medulloblastomas.
Huang J; Grotzer MA; Watanabe T; Hewer E; Pietsch T; Rutkowski S; Ohgaki H
Clin Cancer Res; 2008 Jul; 14(13):4053-8. PubMed ID: 18593981
[TBL] [Abstract][Full Text] [Related]
3. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma.
Cerosaletti KM; Morrison VA; Sabath DE; Willerford DM; Concannon P
Genes Chromosomes Cancer; 2002 Nov; 35(3):282-6. PubMed ID: 12353271
[TBL] [Abstract][Full Text] [Related]
4. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
[TBL] [Abstract][Full Text] [Related]
5. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
[TBL] [Abstract][Full Text] [Related]
6. New mutations and protein variants of NBS1 are identified in cancer cell lines.
Tessitore A; Biordi L; Flati V; Toniato E; Marchetti P; Ricevuto E; Ficorella C; Scotto L; Giannini G; Frati L; Masciocchi C; Tombolini V; Gulino A; Martinotti S
Genes Chromosomes Cancer; 2003 Feb; 36(2):198-204. PubMed ID: 12508248
[TBL] [Abstract][Full Text] [Related]
7. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks.
Digweed M; Sperling K
DNA Repair (Amst); 2004; 3(8-9):1207-17. PubMed ID: 15279809
[TBL] [Abstract][Full Text] [Related]
8. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations.
Medina PP; Ahrendt SA; Pollan M; Fernandez P; Sidransky D; Sanchez-Cespedes M
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):699-704. PubMed ID: 12917199
[TBL] [Abstract][Full Text] [Related]
9. TP53 mutations in malignant astrocytomas.
Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis of deep-seated glioblastomas.
Hayashi Y; Yamashita J; Watanabe T
Cancer Genet Cytogenet; 2004 Aug; 153(1):64-8. PubMed ID: 15325097
[TBL] [Abstract][Full Text] [Related]
11. Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients.
Hama S; Matsuura S; Tauchi H; Sawada J; Kato C; Yamasaki F; Yoshioka H; Sugiyama K; Arita K; Kurisu K; Kamada N; Heike Y; Komatsu K
Anticancer Res; 2000; 20(3B):1897-900. PubMed ID: 10928123
[TBL] [Abstract][Full Text] [Related]
12. High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.
Jesien-Lewandowicz E; Jesionek-Kupnicka D; Zawlik I; Szybka M; Kulczycka-Wojdala D; Rieske P; Sieruta M; Jaskolski D; Och W; Skowronski W; Sikorska B; Potemski P; Papierz W; Liberski PP; Kordek R
Cancer Genet Cytogenet; 2009 Jan; 188(2):77-82. PubMed ID: 19100509
[TBL] [Abstract][Full Text] [Related]
13. Nijmegen breakage syndrome gene (NBS1) is not the tumor suppressor gene at 8q21.3 involved in colorectal carcinoma.
Varon R; Gosse-Brun S; Bignon YJ; Sperling K; Uhrhammer N
Oncol Rep; 2002; 9(4):709-11. PubMed ID: 12066197
[TBL] [Abstract][Full Text] [Related]
14. Ethnicity delineates different genetic pathways in malignant glioma.
Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
[TBL] [Abstract][Full Text] [Related]
15. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations in glioblastoma multiforme.
Hartmann C; Bartels G; Gehlhaar C; Holtkamp N; von Deimling A
Acta Neuropathol; 2005 Jun; 109(6):639-42. PubMed ID: 15924253
[TBL] [Abstract][Full Text] [Related]
18. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair.
Digweed M; Reis A; Sperling K
Bioessays; 1999 Aug; 21(8):649-56. PubMed ID: 10440861
[TBL] [Abstract][Full Text] [Related]
19. Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Wang Y; Hong Y; Li M; Long J; Zhao YP; Zhang JX; Li Q; You H; Tong WM; Jia JD; Huang J
PLoS One; 2013; 8(12):e82426. PubMed ID: 24349281
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia.
Mosor M; Ziółkowska I; Januszkiewicz-Lewandowska D; Nowak J
Eur J Cancer; 2008 Oct; 44(15):2226-32. PubMed ID: 18691878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
